At a Glance

  • Revenues flat
  • Increased interest in stock throughout quarter; corresponding price increase trend
  • Review of 2018 corrective actions on pricing, margin and staffing (with 800 FTE reduction)

Rolling 12 months financials

Stock Performance

Earnings Call Summary

Latest available call date: 2/12/2019

  • Emphasized progress in 2018 on margin recovery and sustainability plan. 2.8% margin for Medicaid 2018. 5% on MA business.
  • Reported $13.7B in Medicaid revenue, with overall 89.4% medical care ratio.
  • Now managing $2B in LTSS benefit designs across business.
  • Reviewed pricing increases on exchange plans in 2018 (60% increases on premiums as corrective action).
  • Recapped renewals in Medicaid: TX, OH, CA, WA and MI. Other wins in PR and MS (CHIP).
  • Portraying renewal of 1/3 of FL contract as positioning for MA and exchange business in FL market.
  • 800 FTEs reduced from beginning of 2018.
  • Estimating $30B of Medicaid opportunities in next 3 years (LA, MN, HI, KY, PA, TN, WV, IN).